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Summary
Background: Neonatal blood stream infections (BSI) are a major cause of morbidity and mortality
in developing countries. It is crucial to continuously monitor the local epidemiology of neonatal
BSI to detect any changes in patterns of infection and susceptibility to various antibiotics.
Objectives: To examine the etiology of BSI in two neonatal intensive care units (NICUs) in the
Republic of Georgia, a resource-poor country, and to determine antibiotic susceptibility of the
isolated organisms.
Methods: A cross-sectional study of all septic infants was conducted in the NICUs of two pediatric
hospitals in Tbilisi between September 2003 and September 2004.
Results: A total of 200 infants with clinical signs of sepsis were admitted to two NICUs. Of these,
126 (63%) had confirmed bacteremia. The mortality rate was 34%. A total of 98 (78%) of 126
recovered isolates were Gram-negative organisms and 28 (22%) were Gram-positive. Klebsiella
pneumoniaewas the most common pathogen, accounting for 36 (29%) of 126 isolates, followed by
Enterobacter cloacae accounting for 19 (15%) and Staphylococcus aureus accounting for 15 (12%).
The Gram-negative organisms showed a high degree of resistance to commonly used antibiotics
such as ampicillin and amoxicillin/clavulanate, and comparatively low resistance to amikacin,
ciprofloxacin, carbapenems, and gentamicin; 40% of S. aureus isolates were methicillin-resistant
(MRSA). In multivariate analysis only umbilical discharge was a significant risk factor for having a
positive blood culture at admission to NICU (prevalence ratio = 2.25, 95% confidence interval
1.82—2.77).
* Corresponding author. Tel.: +1 404 616 3250; fax: +1 404 880 9305.
E-mail address: mkleona@emory.edu (M.K. Leonard).
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Conclusions: Neonatal BSI was mainly caused by Gram-negative organisms, which are developing
resistance to commonly used antibiotics. Understanding the local epidemiology of neonatal BSI
can lead to the development of better medical practices, especially more appropriate choices for
empiric antibiotic therapy, and may contribute to improvement of infection control practices.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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The World Health Organization (WHO) estimates that 130
million infants are born each year. Of these, 8 million do not
survive until their first birthday, and more than 10 million die
before the age of five.1 It is estimated that neonatal deaths
account for a third of global child mortality and that infec-
tions are a major cause of neonatal mortality.2 In the Repub-
lic of Georgia, the neonatal mortality rate in the year 2000
was 25 per 1000 live births, and the infant mortality rate
(under one year of age) was 41 per 1000 live births in 2005.3
Neonatal infections can be acquired vertically through
exposure to bacteria in the birth canal or by exposure after
birth because of a lack of sanitation. Neonatal infections are
primarily sepsis (blood stream infection (BSI)), meningitis,
neonatal tetanus, omphalitis, and diarrhea. In areas where
access toadequatematernalcare is lacking,homebirthsarethe
alternative and sanitary conditions cannot be assured. These
infections are attributed to failures in knowledge and training
regarding basic infection control processes coupledwith inade-
quate infrastructure, systems of care, and resources.4
The rates of BSI in neonates are 3—20 times higher in
developing countries, and in some countries approximately
half of the patients in neonatal intensive care units (NICUs)
acquire an infection, and the case fatality rates may reach
52%.4,5 These numbers are likely a significant underestimate
of the true burden of disease as many babies are born and
may die outside of a hospital, and also within hospitals there
may be lacking laboratory infrastructure for blood cultures.
The high rates of neonatal infections in developing countries
and the types of infections commonly identified such as BSI
with Gram-negative rods, or Staphylococcus aureus infec-
tions, strongly suggest that lack of appropriate hygiene dur-
ing labor and delivery and postnatal care are major
contributors to infectious morbidity in newborns.6—10 The
organisms responsible for neonatal sepsis vary across geo-
graphical boundaries and in time of onset. In addition, one
organism or group of organisms may replace over time
another as the leading cause of neonatal sepsis in a particular
region. It is crucial to continuously monitor the local epide-
miology of neonatal BSI to detect any changes in patterns of
infection and susceptibility to various antibiotics.
The goal of this study was to examine the etiology of BSI in
two NICUs in the Republic of Georgia, a resource-poor coun-
try, and to determine antibiotic susceptibility of the isolated
organisms. Antibiotic use directed at specific pathogens
along with improvements in infection control practices are
two specific aims that better surveillance could impact.
Methods
Study design and patient population
The study had a prospective cross-sectional design. All
infants admitted to the NICUs of two pediatric hospitals(hospital A and hospital B) in Tbilisi, the capital city of the
Republic of Georgia, between September 1, 2003 and Sep-
tember 1, 2004 were enrolled in the study. Hospital A’s NICU is
comprised of six beds with an average of 400 admissions per
year; hospital B’s NICU has eight beds and averages over 540
admissions per year. The admissions to these two NICUs
include children born at other hospitals and transferred to
these facilities, as both hospitals serve as regional referral
NICUs. Eligibility criteria included age of eight weeks or
younger and having clinical manifestations of generalized
infection (neonatal sepsis). The study was approved by the
institutional review board of each hospital in Tbilisi, the
University at Albany, State University of New York, and Emory
University, Atlanta.
Definitions
Clinical criteria of sepsis were the following: temperature
>38 8C or <36 8C, heart rate >20 breaths/min, white blood
cell count 12  109/l or <4  109/l, or >10% of immature
cells, and systemic inflammatory response syndrome (SIRS).
BSI was defined as infection confirmed by blood culture. Low
birth weight was defined as weight of 2500 grams. Prema-
turemembrane rupture was defined as rupture of membranes
before the onset of labor.
Laboratory methods
Two blood samples per patient were drawn at least 30 min
apart from each other. The blood culture system Hemoline
performance diphasic medium (BioMerieux, Marcy l’Etoile,
France) was used for the recovery of pathogens. Blood
culture bottles were incubated for seven days at 37 8C and
visually inspected daily to detect positive growth. Positive
cultures were Gram-stained and subcultured to sheep blood
agar, chocolate agar, MacConkey agar, and Columbia colis-
tin—nalidixic acid agar as per routine bacteriologic guide-
lines. Isolates of bacteria were identified by conventional
biochemical and serological methods. Confirmation of spe-
cies identification was performed by API technique (API-
System, BioMerieux, La Balmes-les Grottes, France) when-
ever there were identification discrepancies. Isolation of
Bacillus spp, Corynebacterium spp, and coagulase-negative
staphylococci recovered from a single culture were consid-
ered as contaminants. A BSI was defined as isolation of at
least one positive peripheral-blood culture, except cases of
infection with coagulase-negative staphylococci, for which
isolation of two positive blood cultures was required.
Susceptibility testing
The antibiotic susceptibility for isolated pathogens was
determined andmet all the recommendations of the National
Committee for Clinical Laboratory Standards breakpoint
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pathogens to clinically used antimicrobials was performed
by using the Kirby—Bauer disk diffusion method and ATB
susceptibility systems (BioMerieux, La Balmes-les Grottes,
France).
Data collection and statistical analysis
Medical records of infants were reviewed and clinical infor-
mation was abstracted. Patient data were recorded on a
standardized data collection form. A survey presented to
mothers of admitted infants provided demographic and
health behavior information. Data were entered in Microsoft
Excel 2000 database (Microsoft Corp., Redmond, WA, USA)
and analyzed using SAS software version 9.1 (SAS Institute,
Cary, NC, USA). Frequencies for demographic data and clin-
ical characteristics were reported. The differences in dis-
tribution of categorical factors were assessed using Mantel—
Haenszel Chi-square test or Fisher’s exact test as appropri-
ate. Prevalence ratios (PR) with 95% confidence intervals
(95% CI) for risk factors of having positive blood culture were
estimated with univariate log-binomial regression models
using PROC GENMOD in SAS. The initial multivariate log-
binomial regression model included risk factors significantly
associated with positive blood culture in univariate analysis
as well as potential confounders. Backward elimination was
used to derive the final model. A p-value of 0.05 was
considered statistically significant.
Results
During the one-year study period a total of 200 infants with
clinical signs of sepsis were admitted to two NICUs. Of theseFigure 1 Study enrollment chart and pathogens200 infants, 112 (56%) were female and 88 (44%) were male.
Themedian age at admission of infants to the NICUwas 4 days
(range 1—43 days). The average length of stay in the NICU
prior to the sepsis episode was 6 days (range 2—30 days). All
200 septic newborns were treated with broad-spectrum anti-
biotics during the current hospitalization. For 73% of
admitted infants, treatment with antibiotics was started in
the first 48 hours of life. Of 200 infants with clinical criteria of
sepsis, 126 (63%) had a confirmed BSI (Figure 1).
The demographic and clinical characteristics of the 200
admitted infants and their mothers are shown in Table 1.
Infants with positive blood cultures were significantly more
likely to have been more than seven days old (PR = 1.52, 95%
CI 1.24—1.85), had umbilical discharge (PR = 2.25, 95% CI
1.82—2.77), and had mothers with positive hepatitis B sur-
face antibodies (anti-HBs) (PR = 1.55, 95% CI 1.28—1.89),
compared to infants with negative blood cultures. In multi-
variate analysis only umbilical discharge was a significant risk
factor for having a positive blood culture at admission to NICU
(PR = 2.25, 95% CI 1.82—2.77). The overall mortality rate was
34% (68 of 200 infants died).Laboratory results
The microorganisms identified in blood cultures of the 126
infants are shown in Figure 1. A total of 98 (78%) of 126
recovered isolates were Gram-negative organisms and 28
(22%) isolates of 126 were Gram-positive. Klebsiella pneu-
moniae was the most common pathogen, accounting for 36
(29%) of 126 isolates, followed by Enterobacter cloacae, 19
(15%). The most common Gram-positive microorganism was
S. aureus— 15 (12%) of 126 isolates. Streptococcus agalactiae
(group B Streptococcus, GBS) was isolated from only six (5%)
infants.
Susceptibility testing results are shown in Tables 2 and 3.
Klebsiella species revealed high susceptibility to imipenemrecovered from blood cultures of 126 infants.
Table 1 Demographic and clinical characteristics of infants with clinical sepsis (N = 200) and their mothers.
Variable Overall
(N = 200)
Positive blood
culture (N = 126)
Negative blood
culture (N = 74)
PRa (95% CI) p-Value
Demographic and clinical characteristics of infants
Gender
Male 88 (44) 59 (47) 29 (39) 1.12 (0.91—1.38) 0.29
Female 112 (56) 67 (53) 45 (61) 1.00
Age at NICU admission
7 days 72 (36) 58 (46) 14 (19) 1.52 (1.24—1.85) <0.001
<7 days 128 (64) 68 (54) 60 (81) 1.00
Birth weight, grams
2500 40 (20) 26 (21) 14 (19) 1.04 (0.80—1.34) 0.77
>2500 160 (80) 100 (79) 60 (81) 1.00
Apgar score
6 64 (32) 44 (35) 20 (27) 1.14 (0.92—1.41) 0.25
>6 136 (68) 82 (65) 54 (73) 1.00
Umbilical discharge
Yes 76 (38) 73 (58) 3 (4) 2.25 (1.82—2.77) <0.001b
No 124 (62) 53 (42) 71 (96) 1.00
Maternal characteristics
Mother’s age, years
18 32 (16) 21 (17) 11 (15) 1.05 (0.80—1.38) 0.74
>19 168 (84) 105 (83) 63 (85) 1.00
Residence
Rural 84 (42) 52 (41) 32 (43) 0.97 (0.78—1.21) 0.79
Urban 116 (58) 74 (59) 42 (57) 1.00
Education
High school or lower 121 (61) 74 (59) 47 (64) 0.93 (0.75—1.15) 0.50
College or higher 79 (39) 52 (41) 27 (36) 1.00
Marriage status
Not married 14 (7) 9 (7) 5 (7) 1.02 (0.68—1.53) 1.00b
Married 186 (93) 117 (93) 69 (93) 1.00
Tobacco use
Yes 13 (7) 8 (6) 5 (7) 0.98 (0.63—1.52) 1.00b
No 187 (93) 118 (94) 69 (93) 1.00
Syphilis (TP antibody test)
Seropositive 13 (7) 10 (8) 3 (4) 1.24 (0.90—1.70) 0.38b
Seronegative 187 (93) 116 (92) 71 (96) 1.00
Hepatitis B surface antibodies (anti-HBs)
Positive 68 (34) 56 (44) 12 (16) 1.55 (1.28—1.89) <0.001
Negative 132 (66) 70 (56) 62 (84) 1.00
Anti-hepatitis C virus antibodies (ELISA)
Positive 10 (5) 7 (6) 3 (4) 1.12 (0.73—1.70) 0.75b
Negative 190 (95) 119 (94) 71 (96) 1.00
Pregnancy and delivery characteristics
First child
Yes 41 (21) 26 (21) 15 (20) 1.01 (0.78—1.31) 0.95
No 159 (79) 100 (79) 59 (80) 1.00
Prenatal care
No 24 (12) 16 (13) 8 (11) 1.07 (0.79—1.45) 0.69
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Table 1 (Continued )
Variable Overall
(N = 200)
Positive blood
culture (N = 126)
Negative blood
culture (N = 74)
PRa (95% CI) p-Value
Yes 176 (88) 110 (87) 66 (89) 1.00
Premature delivery
Yes 29 (15) 21 (17) 8 (11) 1.18 (0.91—1.52) 0.26
No 171 (85) 105 (83) 66 (89) 1.00
Premature membrane rupture
Yes 24 (12) 12 (10) 12 (16) 0.77 (0.51—1.17) 0.16
No 176 (88) 114 (90) 62 (84) 1.00
Type of delivery
Cesarean section 36 (18) 23 (18) 13 (18) 1.02 (0.77—1.34) 0.90
Vaginal 164 (82) 103 (82) 61 (82) 1.00
Results are n (%). PR, prevalence ratio; CI, confidence interval; NICU, neonatal intensive care unit.
a Prevalence ratio for comparison of infants with positive blood culture to the infants with negative blood culture.
b Fisher’s exact test.
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ins. Enterobacter isolates were susceptible to amikacin
(96%), ciprofloxacin (96%), and imipenem (96%), but less so
to the cephalosporins. Forty percent of S. aureus isolates
were methicillin-resistant (MRSA) and all were susceptible to
vancomycin. Escherichia coli strains were susceptible to
ciprofloxacin (91%), carbapenems (91% to imipenem), cefe-
pime (91%), and ceftriaxone (91%), but only 45% susceptibleTable 2 Results of susceptibility testing for Gram-negative isola
Antimicrobials Klebsiella spp
(N = 45) n (%)
susceptible
Enterobacter spp
(N = 23) n (%)
susceptible
Beta-lactam
Ampicillin/sulbactam b b
Amoxicillin 1 (2) 1 (4)
Amoxicillin/clavulanate 34 (76) b
Ticarcillin/clavulanate 37 (82) 13 (57)
Piperacillin/tazobactam 38 (84) 15 (65)
Cefazolin 34 (76) b
Cefepime 40 (89) 19 (83)
Cefotaxime 38 (84) 16 (70)
Ceftazidime 37 (82) 15 (65)
Ceftriaxone 40 (89) 15 (65)
Imipenem 44 (98) 22 (96)
Non-beta-lactam
Amikacin 44 (98) 22 (96)
Gentamicin 40 (89) 21 (91)
Tobramycin 43 (96) 21 (91)
Ciprofloxacin 43 (96) 22 (96)
Moxifloxacin 43 (96) 22 (96)
Tetracycline 34 (76) 16 (70)
TMP—SMX 22 (49) 15 (65)
TMP—SMX, trimethoprim—sulfamethoxazole.
a Susceptibilities for Acinetobacter lwoffi (N = 2), Burkholderia cepaci
(N = 1) were not tested because of small numbers of isolates.
b Not tested for susceptibility to this antibiotic/antimicrobial.to amoxicillin and 64% to trimethoprim—sulfamethoxazole.
Acinetobacter baumannii showed decreased susceptibility to
carbapenems (86% to imipenem) and amikacin (86%). Pseu-
domonas aeruginosa revealed decreased susceptibility to
cefepime (83%), ceftazidime (83%), carbapenems (83% to
imipenem), piperacillin/tazobactam (83%), and ciprofloxacin
(83%). Susceptibility of P. aeruginosa was low to gentamicin
(33%).tes (N = 92a).
Escherichia coli
(N = 11) n (%)
susceptible
Acinetobacter
baumannii (N = 7)
n (%) susceptible
Pseudomonas
aeruginosa (N = 6)
n (%) susceptible
b 5 (71) b
5 (45) b b
7 (64) b b
8 (73) 4 (57) 5 (83)
10 (91) 4 (57) 5 (83)
b b b
10 (91) 4 (57) 5 (83)
10 (91) 2 (29) 5 (83)
10 (91) 4 (57) 5 (83)
10 (91) 2 (29) 5 (83)
10 (91) 6 (86) 5 (83)
10 (91) 6 (86) 4 (67)
9 (82) b 2 (33)
10 (91) 5 (71) 3 (50)
10 (91) 5 (71) 5 (83)
10 (91) 5 (71) 5 (83)
8 (73) 4 (57) b
7 (64) 3 (43) b
a (N = 2), Serratia marcescens (N = 1), and Salmonella choleraesuis
Table 3 Results of susceptibility testing for Gram-positive isolates (N = 28).
Antimicrobials Staphylococcus aureus
(N = 15) n (%) susceptible
Staphylococcus epidermidis
(N = 7) n (%) susceptible
Streptococcus agalactiae
(N = 6) n (%) susceptible
Beta-lactam
Oxacillin 9 (60) 3 (43) a
Amoxicillin 5 (33) 1 (14) a
Amoxicillin/clavulanate 6 (40) 3 (43) a
Piperacillin/tazobactam 11 (73) 3 (43) a
Cefotaxime a a 5 (83)
Ceftriaxone 13 (87) 6 (86) 5 (83)
Imipenem 14 (93) 7 (100) 6 (100)
Meropenem 14 (93) 7 (100) 6 (100)
Non-beta-lactam
Ciprofloxacin 13 (87) 4 (57) 5 (83)
Moxifloxacin 13 (87) 4 (57) 5 (83)
Clindamycin 11 (73) 2 (29) 4 (67)
Erythromycin 10 (67) 2 (29) 3 (50)
Tetracycline 9 (60) 5 (71) 4 (67)
Rifampin 11 (73) 6 (86) 5 (83)
TMP—SMX 13 (87) 3 (43) a
Vancomycin 15 (100) 7 (100) 5 (83)
TMP—SMX, trimethoprim—sulfamethoxazole.
a Not tested for susceptibility to this antibiotic/antimicrobial.
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Since gaining independence in 1991, the ex-Soviet republic of
Georgia has suffered severe socio-economic deterioration
and civil unrest that has significantly affected the healthcare
system.12—14 For example, blood cultures were rarely trusted
in the standardized care of febrile or septic patients due to
the questionable quality of affordable reagents and inability
to process specimens using developed country standards.
Instead, with a lack of microbial susceptibility data, patients
are treated empirically with broad-spectrum antibiotics.
Infection control practices are also underdeveloped and
are known to contribute to the risk of antibiotic resistance.
Our study is the first published study from Georgia to report
the bacterial etiology of neonatal sepsis and to identify the
antimicrobial susceptibility of these organisms.
It is known that the organisms associated with neonatal
infection change over time and are different in different
geographic areas, thus reinforcing the need for local micro-
biological surveillance to guide empiric antimicrobial ther-
apy and to recognize local epidemics and ultimately to help
with overall quality improvement of neonatal care. Neonatal
sepsis in our studied population was caused in 78% of cases by
Gram-negative bacteria (Klebsiella pneumoniae, Enterobac-
ter spp, E. coli, etc.). K. pneumoniaewas themost commonly
isolated pathogen (29%), thus implicating these infections
are hospital-acquired rather than maternally transmitted.
Forty percent of S. aureus isolates were MRSA. These data are
consistent with other reviews of neonatal sepsis in develop-
ing countries where Gram-negative infections are more
frequently isolated, especially Klebsiella, than are Gram-
negative organisms.4,15 A review by Zaidi et al.4 demon-
strated that of 11 471 bloodstream samples throughout thedeveloping world, 60% BSI were caused by Gram-negative
organisms, with K. pneumoniae accounting for 23%, Pseudo-
monas 7%, Acinetobacter 3.5%, and other Gram-negatives
14%. It is well recognized that GBS is an uncommon pathogen
in neonatal sepsis in many parts of the world, while it is the
most common bacterial pathogen associated with early-
onset neonatal sepsis in developed countries.15
The patterns and rates of resistance for the Gram-nega-
tive organisms and for MRSA in this study are surprisingly high
and cause a great deal of concern with respect to infection
control practices and antibiotic prescribing practices. A
relatively high resistance of P. aeruginosa strains against
cephalosporins (cefepime and ceftazidime) was observed,
and Acinetobacter spp demonstrated extensive resistance,
again implicating that the transmission of these organisms is
likely hospital-acquired. Enterobacter infections are a known
surrogate in the NICU for nosocomial transmission.6 Also, the
Gram-negatives Klebsiella, Pseudomonas, and Acinetobacter
are ‘water-bugs’ and can cause common-source outbreaks
because they can live inmulti-usemedication vials, soap, and
inadequately processed equipment.4 The current standard
practice of using empiric ampicillin and gentamicin for sus-
pected neonatal sepsis needs further critical appraisal as this
combination has historically been used to target GBS, E. coli,
and Listeria. However, outside the developed world these are
often not the offending organisms and this standard regimen
may not be active in the face of growing drug resistance seen
primarily among Gram-negative organisms.
The epidemiology of BSI in NICUs in Georgia has not been
previously reported in the literature, nor any hospital-based
BSI data. The extent of hospital-acquired infections in
Georgia and other former Soviet states is not well known.
There is a paucity of data in the medical literature on
Neonatal BSI in Tbilisi 505hospital-acquired infections in the former Soviet states. A
recent observational study of postoperative infection rates
revealed that 17% of operations inGeorgiawere complicated
by infections.16 Understanding the epidemiology of BSI is a
key component in decreasing neonatal mortality. This
knowledge can lead to the development of better medical
practices, especially more appropriate choices for empiric
antibiotic therapy.
The lack of culture driven antimicrobial therapy and
limited, consistent infection control practices is likely
responsible for the resistant Gram-negative BSI in this study.
Next steps to further evaluate the scope of this problem
include improved surveillance of hospital-acquired infec-
tions, education regarding appropriate antibiotic prescrib-
ing, and developing standard infection control practices. If
this problem is not confronted directly, an epidemic of drug-
resistant hospital-acquired infections in Georgia, and likely
other former Soviet republics, could be developing.
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